![]() | ![]() |
Formats:
|
||||||||||||||||||
Copyright © 2007 The Author(s) RNA chaperoning and intrinsic disorder in the core proteins of Flaviviridae 1LaboRetro INSERM #758, Ecole Normale Supérieure de Lyon, IFR 128 Biosciences Lyon-Gerland, 69364 Lyon Cedex 07 and 2Institut de Biologie et Chimie des Protéines, CNRS-UMR 5086, Université Claude Bernard Lyon I, IFR 128 Biosciences Lyon-Gerland, 69367 Lyon Cedex 07, France *To whom correspondence should be addressed. Phone: +33 4 72 72 81 69, Fax: +33 4 72 72 81 37, Email: jldarlix/at/ens-lyon.fr Received August 14, 2007; Revised October 8, 2007; Accepted November 6, 2007. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. This article has been cited by other articles in PMC.Abstract RNA chaperone proteins are essential partners of RNA in living organisms and viruses. They are thought to assist in the correct folding and structural rearrangements of RNA molecules by resolving misfolded RNA species in an ATP-independent manner. RNA chaperoning is probably an entropy-driven process, mediated by the coupled binding and folding of intrinsically disordered protein regions and the kinetically trapped RNA. Previously, we have shown that the core protein of hepatitis C virus (HCV) is a potent RNA chaperone that can drive profound structural modifications of HCV RNA in vitro. We now examined the RNA chaperone activity and the disordered nature of core proteins from different Flaviviridae genera, namely that of HCV, GBV-B (GB virus B), WNV (West Nile virus) and BVDV (bovine viral diarrhoea virus). Despite low-sequence similarities, all four proteins demonstrated general nucleic acid annealing and RNA chaperone activities. Furthermore, heat resistance of core proteins, as well as far-UV circular dichroism spectroscopy suggested that a well-defined 3D protein structure is not necessary for core-induced RNA structural rearrangements. These data provide evidence that RNA chaperoning—possibly mediated by intrinsically disordered protein segments—is conserved in Flaviviridae core proteins. Thus, besides nucleocapsid formation, core proteins may function in RNA structural rearrangements taking place during virus replication. INTRODUCTION Members of the positive-strand RNA virus family Flaviviridae are small, enveloped viruses containing a single-stranded RNA genome. Flaviviridae is classified in three genera (Flavivirus, Pestivirus and Hepacivirus), with important human and/or animal pathogens present in each genus, having considerable global health and socio-economic impacts. Hepatitis C virus (HCV; a hepacivirus) is estimated to infect more than 120 million persons worldwide, corresponding to a prevalence of 2.2–2.5% in the human population (1). Chronic HCV infection may entail serious progressive liver disease, including liver cirrhosis and hepatocellular carcinoma (HCC), and is the most important indication for liver transplantation (2). Major arthropod-borne pathogens of the flaviviruses include West Nile virus (WNV), yellow fever virus (YFV), dengue virus (DEN) and tick-borne encephalitis virus (TBEV); while pestiviruses, including bovine viral diarrhoea virus (BVDV) and classical swine fever virus (CSFV), are animal pathogens infecting livestock and wild ruminants. Viruses from the three genera share fundamental features in their genome organization, replication strategy and virion morphology, but at the same time they exhibit an impressive collection of genus- and virus-specific adaptations (3). The genome of Flaviviridae encodes a single, long polyprotein which is co- and post-translationally processed by cellular and viral proteases to yield the mature structural and non-structural proteins of the virus (3). The core (capsid) protein, located at the N-terminal region of the polyprotein, is a small, highly basic RNA-binding protein that presumably encapsidates and coats the genomic RNA in the viral particle. Besides their highly basic character, core proteins from the three Flaviviridae genera do not exhibit significant sequence similarities or any apparent common features in domain organization. Hepacivirus core proteins (Figure 1
RNA chaperones are abundant proteins in all living organisms and some viruses. They are thought to function by providing assistance to the correct folding of RNA molecules by preventing their misfolding or by resolving misfolded RNA species (17). At every stage of cellular RNA metabolism, including transcription, RNA transport, translation and storage, RNA molecules are associated with a distinct subset of chaperone molecules, which protect them and help in their folding process (18–20). Examples of cellular RNA chaperone proteins include the major messenger ribonucleoprotein particle (mRNP)-associated protein YB-1, the fragile X mental retardation protein (FMRP), and several hnRNP proteins (18). In viruses, human immunodeficiency virus type 1 (HIV-1) nucleocapsid protein represents a canonical example of a multifunctional RNA chaperone (21–23). Importantly, RNA chaperones are able to promote profound structural rearrangements in RNA without ATP consumption. Based on the high proportion of intrinsically unstructured regions in RNA chaperones, Tompa and Csermely (24) recently suggested an elegant model for the ATP-independent mechanism of chaperone function. According to the ‘entropy exchange model’, highly flexible protein regions would undergo disorder-to-order transition upon binding to RNA, concomitantly melting the RNA structure through an entropy exchange process. The de-stabilized RNA then could search the conformational space again, eventually reaching its most stable conformation upon cyclic protein binding and release (24). We previously reported that the core protein of HCV possesses RNA chaperone activities in vitro (25,26). In this study, we examined whether this activity is conserved in the Flaviviridae family. We found that the core proteins of the hepacivirus GBV-B, the pestivirus BVDV and the flavivirus WNV all exhibit RNA chaperone activities in vitro. In addition, since core proteins from the three genera show marked differences in their sequence and domain organization, their shared features may give insights into the underlying common characteristics of RNA chaperones. Thus, using the Flaviviridae core proteins as a model system, we examined whether highly flexible, intrinsically unstructured protein regions play an important role in mediating RNA chaperoning, as predicted by the entropy exchange model. By a combination of far-UV circular dichroism (CD) spectroscopy, heat denaturation and in vitro chaperone assays, we show that short, highly basic and flexible protein segments are a hallmark of active RNA chaperone domains in Flaviviridae core proteins. MATERIALS AND METHODS Proteins and peptides Recombinant HCV genotype 1b core (corresponding to amino acids 2–169 and 2–117; accession number D89872) and GBV-B core (amino acids 2–155; accession number AF179612) proteins were expressed in Escherichia coli and purified as previously described (25,27–28). HCV core proteolytic fragments (amino acids 2–54 and 90–159) were generated by endoproteinase Glu-C cleavage of HCV core(2–169) and purified by HPLC as previously reported (25). WNV core (amino acids 2–105; accession number AF481864) and BVDV core (amino acids 2–91; accession number AF220247) were cloned, expressed and purified as previously reported for HCV core (27) except that the proteins were purified from the E. coli soluble fraction under non-denaturating conditions. All the purified proteins were stored in a buffer containing 20 mM sodium phosphate (pH 7.4) and 5 mM 2-mercaptoethanol and were >95% pure as revealed by SDS–PAGE (Supplementary Figure 1). WNV core peptides were synthesized on an ABI 433 apparatus with Fmoc-OH/DCC/Hobt chemistry. The peptides were cleaved by a TFA solution with classical scavengers and precipitated in diethyl ether. The precipitate was centrifuged and the pellet was solubilized in water and lyophilized. The crude peptides were dissolved in water and purified on Vydac column (C18, 5 µm, 250 × 10 mm) with an appropriate gradient of B (70% acetonitrile, 0.09% TFA solution in water). Purified peptides were characterized by electrospray mass spectrum (SCIEX API 165) at 2567 UMA for peptide WNV 1–24 and 3041 UMA for peptide WNV 80–105, and by HPLC apparatus HP 1100 on analytical column Vydac (C18, 5 µm, 250 × 4.6 mm) in a gradient of 30 min from 10 to 90% of B. Oligodeoxynucleotide (ODN) labelling Oligonucleotides corresponding to the HIV-1 TAR sequence (MAL strain) in the sense and anti-sense orientation were purchased from Eurogentec (Belgium). Tar(+): 5′ G G T C T C T C T T G T T A G A C C A G G T C G A G C C C G G G A G C T C T C T G G C T A G C A A G G A A C C C; Tar(–): 5′ G G G T T C C T T G C T A G C C A G A G A G C T C C C G G G C T C G A C C T G G T C T A A C A A G A G A G A C C. Tar(−) was 32P-labelled with 50 µCi of γ32P-ATP using T4 polynucleotide kinase (Invitrogen), and subsequently purified by 10% PAGE, 7 M urea in 0.5× TBE. In vitro RNA synthesis In order to obtain template DNAs, plasmids pR3 and pS14 were digested by PstI and treated with Klenow polymerase (Invitrogen) to remove 3′ overhangs. In vitro transcription was carried out using T7 RNA polymerase, according to the manufacturer's instructions (Promega). RNAs were labelled by incorporation of α32P-UMP during in vitro transcription. RNAs were purified on a 8% denaturing polyacrylamide gel containing 7 M urea in 50 mM Tris–borate, pH 8.3, 1 mM EDTA (0.5× TBE) and recovered by elution in 0.3 M sodium acetate–0.1% SDS for 4 h at 37°C, followed by ethanol precipitation. DNA annealing Fifteen femtomoles of Tar(+) and equal amounts of 32P-labelled Tar(−) ODNs were incubated with or without protein in 10 µl of annealing buffer (20 mM Tris–HCl, pH 7.0, 30 mM NaCl, 0.1 mM MgCl2, 10 µM ZnCl2 and 5 mM DTT). Standard reactions were performed at 37°C for 5 min, except for the heat-annealed positive control which was incubated at 62°C for 30 min. Protein (peptide)-to-nucleotide molar ratios are indicated in the figure legends. In order to assess the resistance of RNA chaperone activity to heat denaturation, proteins were boiled for 5 min and chilled on ice prior to incubation with the ODNs. Annealing reactions were stopped with 5 µl of 20% glycerol, 20 mM EDTA, pH 8.0, 0.2% SDS, 0.25% bromophenol blue and 0.4 mg/ml calf liver tRNA (29). DNAs were resolved by 8% native PAGE in 50 mM Tris–borate, pH 8.3, 1 mM EDTA (0.5× TBE). Double-stranded versus single-stranded DNA ratios were determined by autoradiography and PhosporImager quantification. Hammerhead ribozyme cleavage R3 ribozyme and S14 substrate RNAs were independently heated for 1 min at 90°C in water. Reaction buffer was added to yield final concentrations of 5 mM MgCl2, 100 mM NaCl, 20 mM Tris–HCl, pH 7.5 and RNAs were slowly cooled down to 37°C. Following a further 5 min incubation at 20°C, 5 nmol R3 and 30 nmol S14 were combined in a final volume of 10 µl, and proteins were added at a final protein-to-nucleotide ratio as indicated in the figure legends. Standard reactions were incubated for 25 min at 37°C and stopped by adding 20 µl of stop solution (0.5% SDS, 25 mM EDTA). RNAs were phenol–chloroform extracted, followed by ethanol precipitation and resuspension of the pellet in 10 µl of loading buffer (45% formamide, 0.5× TBE, and 0.1% bromophenol blue). RNAs were resolved on an 8% denaturing polyacrylamide gel containing 7 M urea in 50 mM Tris–borate, pH 8.3 and 1 mM EDTA (0.5× TBE). Product-to-substrate ratios were determined by autoradiography and PhosporImager quantification. CD spectroscopy CD spectra were recorded on a Chirascan (Applied Photophysics) spectrophotometer. Routinely, measurements were done at 20°C in a 0.02 cm path-length quartz cuvette (Hellma) with protein concentration of 20 µM in 20 mM sodium phosphate buffer (pH 7.4) containing 5 mM 2-mercaptoethanol. Spectra were recorded in the 180–260 nm wavelength range with 0.1 nm increments and 2 s integration times. Protein secondary structure content was determined by using the k2d method of spectral deconvolution at the Dichroweb web facility (http://www.cryst.bbk.ac.uk/cdweb/html/home.html). Denaturation and renaturation were recorded at 222 nm from 20°C to 95°C with a denaturation speed of 1°C/min and with measurement each 0.5°C. RESULTS Prediction of disordered regions in Flaviviridae core proteins RNA chaperone proteins do not share a consensus RNA-binding domain or motif that would make possible their identification from amino acid sequences or structural information alone. However, mostly disordered regions with a highly basic character are probably a hallmark of RNA chaperones (20,24) and, together with clues from protein function, can be considered as an indication for RNA chaperone activities. Indeed, these flexible regions may undergo disorder-to-order transition upon binding to a misfolded RNA structure, and help in its folding process by an entropy exchange mechanism, as proposed by Tompa and Csermely (24). As a proof-of-concept, successful identification of an active RNA chaperone domain in the Gypsy retrotransposon Gag protein—based on disorder prediction and charge distribution—has been reported (30). We used the DisProt VL3-H neural network predictor, developed by Dunker et al. [http://www.ist.temple.edu/disprot/predictor.php (31)] to assess intrinsic disorder in core proteins from the three Flaviviridae genera (Figure 1 HCV and GBV-B core proteins are believed to share a common domain organization (9,36), with an N-terminal, highly basic RNA-binding domain (domain 1 or D1) and a C-terminal, fairly hydrophobic domain (D2), which mediates lipid droplet association of the proteins (7,9). As shown in Figure 1
The crystal structure of WNV core protein and the NMR structure of the related DEN core have recently been reported (40,41). With the exception of amino acid residues 1–20 and a short C-terminal tail, which appear to be highly flexible (40–42), these flavivirus core proteins adopt a compact dimeric fold consisting of four α-helices per monomer, with distinct putative RNA binding and membrane interaction surfaces, proposed based on the asymmetric spatial charge distribution of the dimer (41). According to this model, RNA binding is mediated by the most C-terminal α-helix of the protein. In addition, specific in vitro association of the isolated N- and C-terminal regions (32 and 26 amino acids, respectively) with viral RNA fragments has been reported (43). While hepaci- and flavivirus core proteins contain additional domains besides the markedly basic RNA-binding region(s), BVDV core protein seems to lack distinct functional domains, and shows a uniform charge distribution along its length. Interestingly, BVDV core is predicted to be completely disordered (Figure 1 Flaviviridae core proteins possess DNA-annealing activity Full-length Flaviviridae core proteins were expressed in E. coli with a C-terminal (His)6-tag to facilitate their purification (see Materials and Methods section). The ability of purified proteins to stably bind RNA and DNA was verified by means of mobility shift assays. All four proteins bound both to RNA and DNA without a strict sequence specificity, and they caused complete retention of the nucleic acids at the top of the gel (indicative of the formation of large nucleoprotein complexes) at a protein-to-nucleotide molar ratio of ~1:20 (data not shown). In order to assess the putative nucleic acid chaperone activity of Flaviviridae core proteins, their capacity to enhance the annealing of complementary ODNs was examined. The 56-mer Tar(−) ODN can form a stable hairpin structure, which impedes its hybridization with the complementary Tar(+) ODN. Strand annealing can occur only at high temperatures or in the presence of a protein with nucleic acid chaperone activity [Figure 2
Overall, these results show that Flaviviridae core proteins, despite their highly divergent sequences and markedly different domain organization, all facilitate nucleic acid annealing. Enhancement of hammerhead ribozyme cleavage by Flaviviridae core proteins RNA chaperone proteins can destabilize existing interactions within and between RNA molecules, thus allowing formation of new contacts (44). Due to this mechanism, RNA chaperones can facilitate both the annealing of RNA strands and the unwinding of pre-formed helices. A canonical in vitro assay to examine both facets of RNA chaperoning is the hammerhead ribozyme cleavage assay [(21,45–46), Figure 3
R3 hammerhead ribozyme and 32P-labelled S14 substrate (with a 14-nt long region base-pairing with the ribozyme) were incubated at 37°C for 25 min, together with Flaviviridae core proteins. Following incubation, proteins were removed by phenol–chloroform extraction and RNA products were analysed by PAGE under denaturing conditions. In the absence of protein, cleavage of the substrate occurred slowly, yielding ~15% of product in 25 min at 37°C (Figure 3 The chaperoning activity of Flaviviridae core proteins is resistant to heat denaturation As a first approach to assess whether RNA chaperone activity is really mediated by unstructured proteic regions (24), we examined the heat resistance of Flaviviridae core chaperone function. In contrast to well-folded proteins that usually undergo irreversible denaturation upon heat treatment, intrinsically unstructured proteins (IUPs) are known to be mostly heat resistant (48,49), a property that has been exploited for their purification (50) and large-scale identification (51,52). FL HCV core protein and its deletion mutants, as well as FL GBV-B, WNV and BVDV core proteins were boiled for 5 min, followed by immediate quenching on ice. Chaperone activity without and after boiling was analysed by the capacity of proteins to promote strand annealing of the complementary Tar(−) and Tar(+) ODNs (Figure 2
C-terminally truncated HCV core proteins [core(2–117), corresponding to the D1 domain of the protein, and core(2–54)] exhibited potent annealing activities (Figure 4 Since Tar(−)/Tar(+) complex formation reaches a maximum level extremely rapidly in the presence of Flaviviridae cores, it was possible that a potential decrease in RNA chaperone activity upon boiling of the proteins would be masked by the relatively long incubation time in these assays. In order to compare the kinetics of chaperoning associated with core proteins before and after boiling, we took advantage of the relatively slow reaction rates of the ribozyme cleavage reaction. R3 hammerhead ribozyme and 32P-labelled S14 substrate were incubated together with Flaviviridae core proteins with or without prior boiling. Reactions were stopped after 2, 8, 16 or 30 min of incubation, and the ratio of cleaved versus uncleaved substrate RNA was determined by autoradiography following denaturing gel electrophoresis (Figure 4 Overall, the potent strand annealing activity and facilitation of ribozyme cleavage retained after boiling of the proteins provide convincing evidence that heat resistance is a general feature of Flaviviridae cores. Investigating the secondary structure content of Flaviviridae core proteins In order to get further insights into the structural requirements for RNA chaperoning, we carried out far-UV CD measurements on FL HCV, GBV-B, WNV and BVDV core proteins, and on HCV core(2–117). The secondary structure of HCV core has been well characterized before (36,53), and was included in these studies only for a direct comparison with other Flaviviridae core proteins (Figure 5
In order to examine the effect of temperature on the conformation of core proteins, far-UV CD spectra were recorded at 20°C, followed by slow (1°C/min) heating of the samples up to 95°C, with constant monitoring of thermal unfolding at 222 nm (54,55). A second CD spectrum was recorded at 95°C, and conformational changes associated with the slow (1°C/min) cooling of the samples were followed again at 222 nm. Upon heating of HCV core(2–169) in 0.1% DM, the protein underwent irreversible denaturation, as indicated by the markedly different spectra recorded at 222 nm upon heating and cooling (Figure 6 Similarly to HCV core, adding 0.1% DM to GBV-B core protein led to the formation of partly α-helical structure (Figure 6 In agreement with the available stuctural data on flavivirus capsid proteins (40–42), WNV core exhibited the characteristics of an α-helical protein, with local molar ellipticity minima at 208 and 222 nm (Figure 6 The chaperoning activity of the C-terminal RNA-binding region of WNV core The isolated N- and C-terminal regions of the WNV core protein were found to independently bind RNA (43). Using the strand-annealing assay (Figure 2
The RNA chaperone activity of the WNV (80–105) peptide was further confirmed with the ribozyme cleavage assay, which requires both the strand annealing and helix unwinding activities of a chaperone. In agreement with the results of the strand-annealing assay, WNV (80–105) peptide caused a clear activation of the ribozyme-directed S14 RNA cleavage, while WNV peptide (1–24) did not accelerate the cleavage reaction at all (Figure 7 CD spectroscopy of WNV peptides (1–24) and (80–105) revealed that they are both completely unfolded (Figure 7 DISCUSSION RNA chaperone activity of Flaviviridae core proteins and possible functional implications The genomic RNA (gRNA) of non-segmented positive sense RNA viruses plays complex, temporally and spatially regulated roles throughout the virus life cycle. It serves both as a template for minus-strand RNA or DNA synthesis and as an mRNA directing the translation of viral proteins, and lastly, it is specifically packaged into newly made progeny virions. To accomplish these functions, the gRNA relies at least in part on short specific cis-acting RNA elements (CREs), which regulate viral translation, replication with possible recombination events and virion assembly in infected cells (22–23,56–57). Thus, the gRNA and its CREs most probably undergo complex structural rearrangements, assisted by a virus-encoded protein with nucleic acid chaperone activities. The best-characterized example of a viral nucleic acid chaperone is the small nucleocapsid protein (NCp7) of human immunodeficiency virus type 1 (HIV-1). NCp7 mediates several RNA–RNA and RNA–DNA interactions and gRNA rearrangements that are required at multiple stages of the virus replication cycle, such as initiation and completion of viral DNA synthesis, virus assembly, genome dimerization and packaging (22,23,56). In addition, NCp7 most likely contributes to the genetic variability of HIV-1 by promoting gRNA dimerization, thus enhancing the frequency of copy-choice recombination (58). The core protein of HCV exhibits striking similarities to HIV-1 NCp7, as evidenced by its potent in vitro nucleic acid chaperone activities, facilitating RNA–RNA interactions and structural rearrangements (25,26). Further strengthening the analogy with retroviruses, the genomic RNA of HCV contains a short palindromic CRE mediating dimerization of the gRNA 3′ untranslated region (UTR) upon core protein binding in vitro (25,26). Albeit the physiological relevance of this interaction is still not clear, it is tempting to speculate that RNA structural rearrangements induced by HCV core chaperoning—including genomic RNA dimerization—may constitute regulatory switch(es) between translation/replication or replication/packaging of the viral RNA. The closest relative of HCV is GB virus-B, a hepatotropic virus with unknown natural host range that was shown to be infectious in New World monkeys (59). Even though the similarity between HCV and GBV-B is only ~25–30% at the protein level (60), the two viruses show striking resemblance in virtually every aspect of their replication strategy and structural features, including the tripartite organization of the 3′ UTR, IRES structure and translation mechanism, and lipid droplet association of the core protein (3). By means of classical in vitro RNA chaperone assays (e.g. strand annealing, strand exchange and ribozyme assays; Figures 2 Despite a lack of significant similarity with hepacivirus cores in amino acid sequence or domain organization (Figure 1 Intrinsic disorder and RNA chaperone activity The mechanism of action of RNA chaperone proteins is still not well understood. According to the recently proposed entropy exchange model, intrinsically unstructured, highly flexible protein regions would play an essential role in facilitating RNA structural rearrangements in an ATP-independent manner, probably by providing the energy necessary for partially melting the misfolded RNA structure through an entropy exchange process, coupled with the cyclic RNA binding and release of the protein (24). Experimental evidence for the role of unstructured domains in RNA chaperone function is still scattered and incomplete (20,24). Based on bioinformatic analysis of a dataset consisting of 27 RNA chaperone proteins, Tompa and Csermely (24) found that the frequency of long, continuous disordered fragments in RNA chaperones is considerably higher than in any other protein class examined so far. However, in most cases the protein region responsible for the RNA chaperone function is not precisely mapped, preventing the straightforward assessments of the correlation between disorder and chaperoning. In spite of significant differences in their sequence and domain organization, Flaviviridae core proteins all possess RNA chaperone activities, thus providing an ideal model system to study the common (sequence and structural) requirements for chaperone function. In order to examine whether intrinsic disorder really plays an important role in chaperone activity, we analysed the secondary structure content of Flaviviridae core proteins by far-UV CD spectroscopy both at room temperature, and during thermal denaturation and renaturation. In agreement with in silico predictions (Figure 1 Overall, these experiments show that even closely related RNA chaperones may utilize different strategies and structural features to carry out the same function, and that RNA chaperone activity of Flaviviridae core proteins is mediated by disordered, highly charged protein segments, lending experimental support to the entropy exchange hypothesis. SUPPLEMENTARY DATA Supplementary Data are available at NAR Online. [Supplementary Data]
ACKNOWLEDGEMENTS R.I-N. is the recipient of an ANRS PhD fellowship. We are grateful to Roland Montserret (IBCP CNRS, Lyon) for help and advice on CD spectroscopy measurements and to François Penin (IBCP CNRS, Lyon) for his support and discussions. We thank Philippe Desprès (Institut Pasteur, Paris), Jens Bukh (NIH, Bethesda, USA) and Till Rümenapf (Justus-Liebig-Universität, Giesen, Germany) for their kind gift of plasmids. This work was funded by Agence nationale de recherches sur le sida (to J.-L.D. and J.-P.L.); CNRS and Université Lyon I (to J.-P.L.). Funding to pay the Open Access publication charges for this article was provided by French ANRS. Conflict of interest statement. None declared. REFERENCES 1. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect. Dis. 2005;5:558–567. [PubMed] 2. Brown RS. Hepatitis C and liver transplantation. Nature. 2005;436:973–978. [PubMed] 3. Lindenbach BD, Thiel HJ, Rice CM. Flaviviridae: the viruses and their replication. In: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE, editors. Fields Virology. Philadelphia: Lippincott Williams & Wilkins; 2007. pp. 1101–1152. 4. Hijikata M, Kato N, Ootsuyama Y, Nakagawa M, Shimotohno K. Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. Proc. Natl Acad. Sci. USA. 1991;88:5547–5551. [PubMed] 5. Santolini E, Migliaccio G, La Monica N. Biosynthesis and biochemical properties of the hepatitis C virus core protein. J. Virol. 1994;68:3631–3641. [PubMed] 6. Lemberg MK, Martoglio B. Requirements for signal peptide peptidase-catalyzed intramembrane proteolysis. Mol. Cell. 2002;10:735–744. [PubMed] 7. McLauchlan J, Lemberg MK, Hope G, Martoglio B. Intramembrane proteolysis promotes trafficking of hepatitis C virus core protein to lipid droplets. EMBO J. 2002;21:3980–3988. [PubMed] 8. Hope RG, McLauchlan J. Sequence motifs required for lipid droplet association and protein stability are unique to the hepatitis C virus core protein. J. Gen. Virol. 2000;81:1913–1925. [PubMed] 9. Hope RG, Murphy DJ, McLauchlan J. The domains required to direct core proteins of hepatitis C virus and GB virus-B to lipid droplets share common features with plant oleosin proteins. J. Biol. Chem. 2002;277:4261–4270. [PubMed] 10. Lobigs M. Flavivirus premembrane protein cleavage and spike heterodimer secretion require the function of the viral proteinase NS3. Proc. Natl Acad. Sci. USA. 1993;90:6218–6222. [PubMed] 11. Amberg SM, Nestorowicz A, McCourt DW, Rice CM. NS2B-3 proteinase-mediated processing in the yellow fever virus structural region: in vitro and in vivo studies. J. Virol. 1994;68:3794–3802. [PubMed] 12. Yamshchikov VF, Compans RW. Processing of the intracellular form of the West Nile virus capsid protein by the viral NS2B-NS3 protease: an in vitro study. J. Virol. 1994;68:5765–5771. [PubMed] 13. Rümenapf T, Unger G, Strauss JH, Thiel HJ. Processing of the envelope glycoproteins of pestiviruses. J. Virol. 1993;67:3288–3294. [PubMed] 14. Stark R, Meyers G, Rümenapf T, Thiel HJ. Processing of pestivirus polyprotein: cleavage site between autoprotease and nucleocapsid protein of classical swine fever virus. J. Virol. 1993;67:7088–7095. [PubMed] 15. Rümenapf T, Stark R, Heimann M, Thiel HJ. N-terminal protease of pestiviruses: identification of putative catalytic residues by site-directed mutagenesis. J. Virol. 1998;72:2544–2547. [PubMed] 16. Heimann M, Roman-Sosa G, Martoglio B, Thiel HJ, Rümenapf T. Core protein of pestiviruses is processed at the C terminus by signal peptide peptidase. J. Virol. 2006;80:1915–1921. [PubMed] 17. Herschlag D. RNA chaperones and the RNA folding problem. J. Biol. Chem. 1995;270:20871–20874. [PubMed] 18. Cristofari G, Darlix JL. The ubiquitous nature of RNA chaperone proteins. Prog. Nucleic Acid Res. Mol. Biol. 2002;72:223–268. [PubMed] 19. Schroeder R, Barta A, Semrad K. Strategies for RNA folding and assembly. Nat. Rev. Mol. Cell Biol. 2004;5:908–919. [PubMed] 20. Ivanyi-Nagy R, Davidovic L, Khandjian EW, Darlix JL. Disordered RNA chaperone proteins: from functions to disease. Cell. Mol. Life Sci. 2005;62:1409–1417. [PubMed] 21. Bertrand EL, Rossi JJ. Facilitation of hammerhead ribozyme catalysis by the nucleocapsid protein of HIV-1 and the heterogeneous nuclear ribonucleoprotein A1. EMBO J. 1994;13:2904–2912. [PubMed] 22. Darlix JL, Lapadat-Tapolsky M, de Rocquigny H, Roques BP. First glimpses at structure-function relationships of the nucleocapsid protein of retroviruses. J. Mol. Biol. 1995;254:523–537. [PubMed] 23. Rein A, Henderson LE, Levin JG. Nucleic-acid-chaperone activity of retroviral nucleocapsid proteins: significance for viral replication. Trends Biochem. Sci. 1998;23:297–301. [PubMed] 24. Tompa P, Csermely P. The role of structural disorder in the function of RNA and protein chaperones. FASEB J. 2004;18:1169–1175. [PubMed] 25. Cristofari G, Ivanyi-Nagy R, Gabus C, Boulant S, Lavergne JP, Penin F, Darlix JL. The hepatitis C virus Core protein is a potent nucleic acid chaperone that directs dimerization of the viral (+) strand RNA in vitro. Nucleic Acids Res. 2004;32:2623–2631. [PubMed] 26. Ivanyi-Nagy R, Kanevsky I, Gabus C, Lavergne JP, Ficheux D, Penin F, Fossé P, Darlix JL. Analysis of hepatitis C virus RNA dimerization and core-RNA interactions. Nucleic Acids Res. 2006;34:2618–2633. [PubMed] 27. Boulant S, Becchi M, Penin F, Lavergne JP. Unusual multiple recoding events leading to alternative forms of hepatitis C virus core protein from genotype 1b. J. Biol. Chem. 2003;278:45785–45792. [PubMed] 28. Boni S, Lavergne JP, Boulant S, Cahour A. Hepatitis C virus core protein acts as a trans-modulating factor on internal translation initiation of the viral RNA. J. Biol. Chem. 2005;280:17737–17748. [PubMed] 29. Tsuchihashi Z, Brown PO. DNA strand exchange and selective DNA annealing promoted by the human immunodeficiency virus type 1 nucleocapsid protein. J. Virol. 1994;68:5863–5870. [PubMed] 30. Gabus C, Ivanyi-Nagy R, Depollier J, Bucheton A, Pelisson A, Darlix JL. Characterization of a nucleocapsid-like region and of two distinct primer tRNALys,2 binding sites in the endogenous retrovirus Gypsy. Nucleic Acids Res. 2006;34:5764–5777. [PubMed] 31. Obradovic Z, Peng K, Vucetic S, Radivojac P, Brown CJ, Dunker AK. Predicting intrinsic disorder from amino acid sequence. Proteins. 2003;53(Suppl. 6):566–572. [PubMed] 32. Dosztányi Z, Csizmók V, Tompa P, Simon I. IUPred: web server for the prediction of intrinsically unstructured regions of proteins based on estimated energy content. Bioinformatics. 2005;21:3433–3434. [PubMed] 33. Prilusky J, Felder CE, Zeev-Ben-Mordehai T, Rydberg EH, Man O, Beckmann JS, Silman I, Sussman JL. FoldIndex: a simple tool to predict whether a given protein sequence is intrinsically unfolded. Bioinformatics. 2005;21:3435–3438. [PubMed] 34. Dosztányi Z, Csizmók V, Tompa P, Simon I. The pairwise energy content estimated from amino acid composition discriminates between folded and intrinsically unstructured proteins. J. Mol. Biol. 2005;347:827–839. [PubMed] 35. Uversky VN, Gillespie JR, Fink AL. Why are “natively unfolded” proteins unstructured under physiologic conditions? Proteins. 2000;41:415–427. [PubMed] 36. Boulant S, Vanbelle C, Ebel C, Penin F, Lavergne JP. Hepatitis C virus core protein is a dimeric alpha-helical protein exhibiting membrane protein features. J. Virol. 2005;79:11353–11365. [PubMed] 37. Boulant S, Montserret R, Hope RG, Ratinier M, Targett-Adams P, Lavergne JP, Penin F, McLauchlan J. Structural determinants that target the hepatitis C virus core protein to lipid droplets. J. Biol. Chem. 2006;281:22236–22247. [PubMed] 38. Klein KC, Polyak SJ, Lingappa JR. Unique features of hepatitis C virus capsid formation revealed by de novo cell-free assembly. J. Virol. 2004;78:9257–9269. [PubMed] 39. Majeau N, Gagne V, Boivin A, Bolduc M, Majeau JA, Ouellet D, Leclerc D. The N-terminal half of the core protein of hepatitis C virus is sufficient for nucleocapsid formation. J. Gen. Virol. 2004;85:971–981. [PubMed] 40. Dokland T, Walsh M, Mackenzie JM, Khromykh AA, Ee KH, Wang S. West Nile virus core protein; tetramer structure and ribbon formation. Structure. 2004;12:1157–1163. [PubMed] 41. Ma L, Jones CT, Groesch TD, Kuhn RJ, Post CB. Solution structure of dengue virus capsid protein reveals another fold. Proc. Natl Acad. Sci. USA. 2004;101:3414–3419. [PubMed] 42. Jones CT, Ma L, Burgner JW, Groesch TD, Post CB, Kuhn RJ. Flavivirus capsid is a dimeric alpha-helical protein. J. Virol. 2003;77:7143–7149. [PubMed] 43. Khromykh AA, Westaway EG. RNA binding properties of core protein of the flavivirus Kunjin. Arch. Virol. 1996;141:685–699. [PubMed] 44. Waldsich C, Grossberger R, Schroeder R. RNA chaperone StpA loosens interactions of the tertiary structure in the td group I intron in vivo. Genes Dev. 2002;16:2300–2312. [PubMed] 45. Tsuchihashi Z, Khosla M, Herschlag D. Protein enhancement of hammerhead ribozyme catalysis. Science. 1993;262:99–102. [PubMed] 46. Herschlag D, Khosla M, Tsuchihashi Z, Karpel RL. An RNA chaperone activity of non-specific RNA binding proteins in hammerhead ribozyme catalysis. EMBO J. 1994;13:2913–2924. [PubMed] 47. Gabus C, Mazroui R, Tremblay S, Khandjian EW, Darlix JL. The fragile X mental retardation protein has nucleic acid chaperone properties. Nucleic Acids Res. 2004;32:2129–2137. [PubMed] 48. Weinreb PH, Zhen W, Poon AW, Conway KA, Lansbury PT., Jr NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. Biochemistry. 1996;35:13709–13715. [PubMed] 49. Receveur-Bréchot V, Bourhis JM, Uversky VN, Canard B, Longhi S. Assessing protein disorder and induced folding. Proteins. 2006;62:24–45. [PubMed] 50. Kalthoff C. A novel strategy for the purification of recombinantly expressed unstructured protein domains. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2003;786:247–254. 51. Csizmók V, Szollosi E, Friedrich P, Tompa P. A novel two-dimensional electrophoresis technique for the identification of intrinsically unstructured proteins. Mol. Cell. Proteomics. 2006;5:265–273. [PubMed] 52. Csizmók V, Dosztányi Z, Simon I, Tompa P. Towards proteomic approaches for the identification of structural disorder. Curr. Protein Pept. Sci. 2007;8:173–179. [PubMed] 53. Kunkel M, Watowich SJ. Biophysical characterization of hepatitis C virus core protein: implications for interactions within the virus and host. FEBS Lett. 2004;557:174–180. [PubMed] 54. Kim TD, Ryu HJ, Cho HI, Yang CH, Kim J. Thermal behavior of proteins: heat-resistant proteins and their heat-induced secondary structural changes. Biochemistry. 2000;39:14839–14846. [PubMed] 55. Uversky VN. What does it mean to be natively unfolded? Eur. J. Biochem. 2002;269:2–12. [PubMed] 56. Darlix JL, Garrido JL, Morellet N, Mély Y, Rocquigny H. Properties, functions, and drug targeting of the multifunctional nucleocapsid protein of the human immunodeficiency virus. Adv. Pharmacol. 2007;55:299–346. [PubMed] 57. Moradpour D, Penin F, Rice CM. Replication of hepatitis C virus. Nat. Rev. Microbiol. 2007;5:453–463. [PubMed] 58. Negroni M, Buc H. Copy-choice recombination by reverse transcriptases: reshuffling of genetic markers mediated by RNA chaperones. Proc. Natl Acad. Sci. USA. 2000;97:6385–6390. [PubMed] 59. Bukh J, Apgar CL, Govindarajan S, Purcell RH. Host range studies of GB virus-B hepatitis agent, the closest relative of hepatitis C virus, in New World monkeys and chimpanzees. J. Med. Virol. 2001;65:694–697. [PubMed] 60. Muerhoff AS, Leary TP, Simons JN, Pilot-Matias TJ, Dawson GJ, Erker JC, Chalmers ML, Schlauder GG, Desai SM, et al. Genomic organization of GB viruses A and B: two new members of the Flaviviridae associated with GB agent hepatitis. J. Virol. 1995;69:5621–5630. [PubMed] 61. Khromykh AA, Meka H, Guyatt KJ, Westaway EG. Essential role of cyclization sequences in flavivirus RNA replication. J. Virol. 2001;75:6719–6728. [PubMed] 62. Lo MK, Tilgner M, Bernard KA, Shi PY. Functional analysis of mosquito-borne flavivirus conserved sequence elements within 3′ untranslated region of West Nile virus by use of a reporting replicon that differentiates between viral translation and RNA replication. J. Virol. 2003;77:10004–10014. [PubMed] 63. Alvarez DE, Lodeiro MF, Luduena SJ, Pietrasanta LI, Gamarnik AV. Long-range RNA–RNA interactions circularize the dengue virus genome. J. Virol. 2005;79:6631–6643. [PubMed] 64. Filomatori CV, Lodeiro MF, Alvarez DE, Samsa MM, Pietrasanta L, Gamarnik AV. A 5' RNA element promotes dengue virus RNA synthesis on a circular genome. Genes Dev. 2006;20:2238–2249. [PubMed] |
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||
Lancet Infect Dis. 2005 Sep; 5(9):558-67.
[Lancet Infect Dis. 2005]Nature. 2005 Aug 18; 436(7053):973-8.
[Nature. 2005]Proc Natl Acad Sci U S A. 1991 Jul 1; 88(13):5547-51.
[Proc Natl Acad Sci U S A. 1991]J Virol. 1994 Jun; 68(6):3631-41.
[J Virol. 1994]Mol Cell. 2002 Oct; 10(4):735-44.
[Mol Cell. 2002]EMBO J. 2002 Aug 1; 21(15):3980-8.
[EMBO J. 2002]J Virol. 1994 Jun; 68(6):3631-41.
[J Virol. 1994]J Biol Chem. 1995 Sep 8; 270(36):20871-4.
[J Biol Chem. 1995]Prog Nucleic Acid Res Mol Biol. 2002; 72():223-68.
[Prog Nucleic Acid Res Mol Biol. 2002]Nat Rev Mol Cell Biol. 2004 Nov; 5(11):908-19.
[Nat Rev Mol Cell Biol. 2004]Cell Mol Life Sci. 2005 Jul; 62(13):1409-17.
[Cell Mol Life Sci. 2005]Prog Nucleic Acid Res Mol Biol. 2002; 72():223-68.
[Prog Nucleic Acid Res Mol Biol. 2002]FASEB J. 2004 Aug; 18(11):1169-75.
[FASEB J. 2004]Nucleic Acids Res. 2004; 32(8):2623-31.
[Nucleic Acids Res. 2004]Nucleic Acids Res. 2006; 34(9):2618-33.
[Nucleic Acids Res. 2006]Nucleic Acids Res. 2004; 32(8):2623-31.
[Nucleic Acids Res. 2004]J Biol Chem. 2003 Nov 14; 278(46):45785-92.
[J Biol Chem. 2003]J Biol Chem. 2005 May 6; 280(18):17737-48.
[J Biol Chem. 2005]J Biol Chem. 2003 Nov 14; 278(46):45785-92.
[J Biol Chem. 2003]J Virol. 1994 Sep; 68(9):5863-70.
[J Virol. 1994]Cell Mol Life Sci. 2005 Jul; 62(13):1409-17.
[Cell Mol Life Sci. 2005]FASEB J. 2004 Aug; 18(11):1169-75.
[FASEB J. 2004]Nucleic Acids Res. 2006; 34(20):5764-77.
[Nucleic Acids Res. 2006]Proteins. 2003; 53 Suppl 6():566-72.
[Proteins. 2003]Bioinformatics. 2005 Aug 15; 21(16):3433-4.
[Bioinformatics. 2005]Bioinformatics. 2005 Aug 15; 21(16):3435-8.
[Bioinformatics. 2005]J Mol Biol. 2005 Apr 8; 347(4):827-39.
[J Mol Biol. 2005]Proteins. 2000 Nov 15; 41(3):415-27.
[Proteins. 2000]J Biol Chem. 2002 Feb 8; 277(6):4261-70.
[J Biol Chem. 2002]J Virol. 2005 Sep; 79(17):11353-65.
[J Virol. 2005]EMBO J. 2002 Aug 1; 21(15):3980-8.
[EMBO J. 2002]J Biol Chem. 2006 Aug 4; 281(31):22236-47.
[J Biol Chem. 2006]J Virol. 1994 Jun; 68(6):3631-41.
[J Virol. 1994]Structure. 2004 Jul; 12(7):1157-63.
[Structure. 2004]Proc Natl Acad Sci U S A. 2004 Mar 9; 101(10):3414-9.
[Proc Natl Acad Sci U S A. 2004]Structure. 2004 Jul; 12(7):1157-63.
[Structure. 2004]Proc Natl Acad Sci U S A. 2004 Mar 9; 101(10):3414-9.
[Proc Natl Acad Sci U S A. 2004]J Virol. 2003 Jun; 77(12):7143-9.
[J Virol. 2003]Prog Nucleic Acid Res Mol Biol. 2002; 72():223-68.
[Prog Nucleic Acid Res Mol Biol. 2002]Nucleic Acids Res. 2004; 32(8):2623-31.
[Nucleic Acids Res. 2004]Genes Dev. 2002 Sep 1; 16(17):2300-12.
[Genes Dev. 2002]EMBO J. 1994 Jun 15; 13(12):2904-12.
[EMBO J. 1994]Science. 1993 Oct 1; 262(5130):99-102.
[Science. 1993]EMBO J. 1994 Jun 15; 13(12):2913-24.
[EMBO J. 1994]Science. 1993 Oct 1; 262(5130):99-102.
[Science. 1993]FASEB J. 2004 Aug; 18(11):1169-75.
[FASEB J. 2004]Biochemistry. 1996 Oct 29; 35(43):13709-15.
[Biochemistry. 1996]Proteins. 2006 Jan 1; 62(1):24-45.
[Proteins. 2006]Mol Cell Proteomics. 2006 Feb; 5(2):265-73.
[Mol Cell Proteomics. 2006]Curr Protein Pept Sci. 2007 Apr; 8(2):173-9.
[Curr Protein Pept Sci. 2007]Structure. 2004 Jul; 12(7):1157-63.
[Structure. 2004]Nature. 2005 Aug 18; 436(7053):973-8.
[Nature. 2005]Proc Natl Acad Sci U S A. 1991 Jul 1; 88(13):5547-51.
[Proc Natl Acad Sci U S A. 1991]J Virol. 1994 Jun; 68(6):3631-41.
[J Virol. 1994]Mol Cell. 2002 Oct; 10(4):735-44.
[Mol Cell. 2002]EMBO J. 2002 Aug 1; 21(15):3980-8.
[EMBO J. 2002]J Virol. 2005 Sep; 79(17):11353-65.
[J Virol. 2005]FEBS Lett. 2004 Jan 16; 557(1-3):174-80.
[FEBS Lett. 2004]Biochemistry. 2000 Dec 5; 39(48):14839-46.
[Biochemistry. 2000]Eur J Biochem. 2002 Jan; 269(1):2-12.
[Eur J Biochem. 2002]Structure. 2004 Jul; 12(7):1157-63.
[Structure. 2004]Proc Natl Acad Sci U S A. 2004 Mar 9; 101(10):3414-9.
[Proc Natl Acad Sci U S A. 2004]J Virol. 2003 Jun; 77(12):7143-9.
[J Virol. 2003]Structure. 2004 Jul; 12(7):1157-63.
[Structure. 2004]Arch Virol. 1996; 141(3-4):685-99.
[Arch Virol. 1996]Prog Nucleic Acid Res Mol Biol. 2002; 72():223-68.
[Prog Nucleic Acid Res Mol Biol. 2002]Cell Mol Life Sci. 2005 Jul; 62(13):1409-17.
[Cell Mol Life Sci. 2005]J Mol Biol. 1995 Dec 8; 254(4):523-37.
[J Mol Biol. 1995]Trends Biochem Sci. 1998 Aug; 23(8):297-301.
[Trends Biochem Sci. 1998]Adv Pharmacol. 2007; 55():299-346.
[Adv Pharmacol. 2007]Nat Rev Microbiol. 2007 Jun; 5(6):453-63.
[Nat Rev Microbiol. 2007]J Mol Biol. 1995 Dec 8; 254(4):523-37.
[J Mol Biol. 1995]Nucleic Acids Res. 2004; 32(8):2623-31.
[Nucleic Acids Res. 2004]Nucleic Acids Res. 2006; 34(9):2618-33.
[Nucleic Acids Res. 2006]J Med Virol. 2001 Dec; 65(4):694-7.
[J Med Virol. 2001]J Virol. 1995 Sep; 69(9):5621-30.
[J Virol. 1995]J Virol. 2001 Jul; 75(14):6719-28.
[J Virol. 2001]J Virol. 2003 Sep; 77(18):10004-14.
[J Virol. 2003]J Virol. 2005 Jun; 79(11):6631-43.
[J Virol. 2005]Genes Dev. 2006 Aug 15; 20(16):2238-49.
[Genes Dev. 2006]FASEB J. 2004 Aug; 18(11):1169-75.
[FASEB J. 2004]Cell Mol Life Sci. 2005 Jul; 62(13):1409-17.
[Cell Mol Life Sci. 2005]J Biol Chem. 2002 Feb 8; 277(6):4261-70.
[J Biol Chem. 2002]J Biol Chem. 2006 Aug 4; 281(31):22236-47.
[J Biol Chem. 2006]Structure. 2004 Jul; 12(7):1157-63.
[Structure. 2004]Nucleic Acids Res. 2006; 34(9):2618-33.
[Nucleic Acids Res. 2006]